Golden Rice opposition cost $2b and 1.4m ‘life years’ over 10 years in India alone

px Golden Rice
Image via Wikimedia.org

Golden Rice, genetically engineered to include Vitamin A, has been available since 2000, but has yet to be introduced to any country. The rice, which researchers hope will provide much-needed nutrients to poorer populations, is controversial among those concerned about the long-term impacts of GMOs. As debate over Golden Rice ensues, countries like India suffer, according to a new study from the journal Environment and Development Economics.

To study the economic and social impacts the authors developed “a real option model including irreversibility and uncertainty about perceived costs and arrival of new information to explain a delay in approval. The model has been applied to the case of India. Results show the annual perceived costs have to be at least US$199 million per year approximately for the last decade to explain the delay in approval of the technology. This is an indicator of the economic power of the opposition towards Golden Rice resulting in about 1.4 million life years lost over the past decade in India.”

Read the full study here.

Additional Resources:

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.noReviewsLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-07-30-at-3.07.42-PM
Controversy over WNBA star Sophie Cunningham’s comment opposing trans females in women’s sports reinvigorates the culture wars
leeteam
How Kennedy and his family could pocket millions from Merck’s $50 million vaccine injury settlement that he oversaw
ChatGPT-Image-Jul-10-2026-12_21_03-PM
Viewpoint: Is there new evidence that the animal deworming drug ivermectin decreases the risk of Covid and cancer? Don’t waste your money.
Screenshot-2026-07-30-at-2.30.35-PM
Climate scientists claim conservative activists are promoting ‘lies’ that Europe’s summer heatwaves are far from unusual
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-07-09-at-1.09.25-PM
Anti-vaccine myths rattle health care
Picture1
Hiroshima at 81: America’s new nuclear bomb, a buried Iranian target, and a question no one wants to ask
ChatGPT Image Jul 29, 2026, 12_05_21 PM
AI-generated physicians promoting bogus cures and worthless supplements surge on social media
ChatGPT Image Jul 29, 2026, 05_50_04 PM
Fear, science, and the law: If talc powder is unlikely to cause cancer and J&J was winning in court, why did it pay more than $5.5 billion to settle?
ChatGPT Image Jul 29, 2026, 06_26_01 PM 2
Facts & Fallacies podcast: Organic food myths make a comeback on Instagram, with Dr. Kevin Folta
ChatGPT Image Jul 29, 2026, 10_14_27 PM
After muzzling RFK, Jr. over autism-vaccine conspiracy theories, Trump defies aides to push scares again
Screenshot 2026-07-22 at 1.38
Viewpoint: Are the U.S. and Europe headed towards a repudiation of agricultural biotechnology red tape?

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.